Copyright Reports & Markets. All rights reserved.

Global Prostate Cancer Therapeutics Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Prostate Cancer Therapeutics Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Prostate Cancer Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Drugs
    • 1.4.3 Medical Devices
  • 1.5 Market by Application
    • 1.5.1 Global Prostate Cancer Therapeutics Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospital Pharmacy
    • 1.5.3 Retail Pharmacy
    • 1.5.4 Online Sales
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Prostate Cancer Therapeutics Market Perspective (2015-2026)
  • 2.2 Global Prostate Cancer Therapeutics Growth Trends by Regions
    • 2.2.1 Prostate Cancer Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Prostate Cancer Therapeutics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Prostate Cancer Therapeutics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Prostate Cancer Therapeutics Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Prostate Cancer Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Prostate Cancer Therapeutics Players by Market Size
    • 3.1.1 Global Top Prostate Cancer Therapeutics Players by Revenue (2015-2020)
    • 3.1.2 Global Prostate Cancer Therapeutics Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Prostate Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Prostate Cancer Therapeutics Market Concentration Ratio
    • 3.2.1 Global Prostate Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Prostate Cancer Therapeutics Revenue in 2019
  • 3.3 Prostate Cancer Therapeutics Key Players Head office and Area Served
  • 3.4 Key Players Prostate Cancer Therapeutics Product Solution and Service
  • 3.5 Date of Enter into Prostate Cancer Therapeutics Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Prostate Cancer Therapeutics Historic Market Size by Type (2015-2020)
  • 4.2 Global Prostate Cancer Therapeutics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Prostate Cancer Therapeutics Market Size by Application (2015-2020)
  • 5.2 Global Prostate Cancer Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Prostate Cancer Therapeutics Market Size (2015-2020)
  • 6.2 Prostate Cancer Therapeutics Key Players in North America (2019-2020)
  • 6.3 North America Prostate Cancer Therapeutics Market Size by Type (2015-2020)
  • 6.4 North America Prostate Cancer Therapeutics Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Prostate Cancer Therapeutics Market Size (2015-2020)
  • 7.2 Prostate Cancer Therapeutics Key Players in Europe (2019-2020)
  • 7.3 Europe Prostate Cancer Therapeutics Market Size by Type (2015-2020)
  • 7.4 Europe Prostate Cancer Therapeutics Market Size by Application (2015-2020)

8 China

  • 8.1 China Prostate Cancer Therapeutics Market Size (2015-2020)
  • 8.2 Prostate Cancer Therapeutics Key Players in China (2019-2020)
  • 8.3 China Prostate Cancer Therapeutics Market Size by Type (2015-2020)
  • 8.4 China Prostate Cancer Therapeutics Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Prostate Cancer Therapeutics Market Size (2015-2020)
  • 9.2 Prostate Cancer Therapeutics Key Players in Japan (2019-2020)
  • 9.3 Japan Prostate Cancer Therapeutics Market Size by Type (2015-2020)
  • 9.4 Japan Prostate Cancer Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Prostate Cancer Therapeutics Market Size (2015-2020)
  • 10.2 Prostate Cancer Therapeutics Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Prostate Cancer Therapeutics Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Prostate Cancer Therapeutics Market Size by Application (2015-2020)

11 India

  • 11.1 India Prostate Cancer Therapeutics Market Size (2015-2020)
  • 11.2 Prostate Cancer Therapeutics Key Players in India (2019-2020)
  • 11.3 India Prostate Cancer Therapeutics Market Size by Type (2015-2020)
  • 11.4 India Prostate Cancer Therapeutics Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Prostate Cancer Therapeutics Market Size (2015-2020)
  • 12.2 Prostate Cancer Therapeutics Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Prostate Cancer Therapeutics Market Size by Type (2015-2020)
  • 12.4 Central & South America Prostate Cancer Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Sanofi
    • 13.1.1 Sanofi Company Details
    • 13.1.2 Sanofi Business Overview
    • 13.1.3 Sanofi Prostate Cancer Therapeutics Introduction
    • 13.1.4 Sanofi Revenue in Prostate Cancer Therapeutics Business (2015-2020))
    • 13.1.5 Sanofi Recent Development
  • 13.2 Pfizer
    • 13.2.1 Pfizer Company Details
    • 13.2.2 Pfizer Business Overview
    • 13.2.3 Pfizer Prostate Cancer Therapeutics Introduction
    • 13.2.4 Pfizer Revenue in Prostate Cancer Therapeutics Business (2015-2020)
    • 13.2.5 Pfizer Recent Development
  • 13.3 Amgen
    • 13.3.1 Amgen Company Details
    • 13.3.2 Amgen Business Overview
    • 13.3.3 Amgen Prostate Cancer Therapeutics Introduction
    • 13.3.4 Amgen Revenue in Prostate Cancer Therapeutics Business (2015-2020)
    • 13.3.5 Amgen Recent Development
  • 13.4 Johnson & Johnson
    • 13.4.1 Johnson & Johnson Company Details
    • 13.4.2 Johnson & Johnson Business Overview
    • 13.4.3 Johnson & Johnson Prostate Cancer Therapeutics Introduction
    • 13.4.4 Johnson & Johnson Revenue in Prostate Cancer Therapeutics Business (2015-2020)
    • 13.4.5 Johnson & Johnson Recent Development
  • 13.5 AstraZeneca
    • 13.5.1 AstraZeneca Company Details
    • 13.5.2 AstraZeneca Business Overview
    • 13.5.3 AstraZeneca Prostate Cancer Therapeutics Introduction
    • 13.5.4 AstraZeneca Revenue in Prostate Cancer Therapeutics Business (2015-2020)
    • 13.5.5 AstraZeneca Recent Development
  • 13.6 AbbVie
    • 13.6.1 AbbVie Company Details
    • 13.6.2 AbbVie Business Overview
    • 13.6.3 AbbVie Prostate Cancer Therapeutics Introduction
    • 13.6.4 AbbVie Revenue in Prostate Cancer Therapeutics Business (2015-2020)
    • 13.6.5 AbbVie Recent Development
  • 13.7 Bayer
    • 13.7.1 Bayer Company Details
    • 13.7.2 Bayer Business Overview
    • 13.7.3 Bayer Prostate Cancer Therapeutics Introduction
    • 13.7.4 Bayer Revenue in Prostate Cancer Therapeutics Business (2015-2020)
    • 13.7.5 Bayer Recent Development
  • 13.8 Ipsen Group
    • 13.8.1 Ipsen Group Company Details
    • 13.8.2 Ipsen Group Business Overview
    • 13.8.3 Ipsen Group Prostate Cancer Therapeutics Introduction
    • 13.8.4 Ipsen Group Revenue in Prostate Cancer Therapeutics Business (2015-2020)
    • 13.8.5 Ipsen Group Recent Development
  • 13.9 Endo Pharmaceuticals
    • 13.9.1 Endo Pharmaceuticals Company Details
    • 13.9.2 Endo Pharmaceuticals Business Overview
    • 13.9.3 Endo Pharmaceuticals Prostate Cancer Therapeutics Introduction
    • 13.9.4 Endo Pharmaceuticals Revenue in Prostate Cancer Therapeutics Business (2015-2020)
    • 13.9.5 Endo Pharmaceuticals Recent Development
  • 13.10 Dendreon Corporation (Sanpower Group Co. Ltd.)
    • 13.10.1 Dendreon Corporation (Sanpower Group Co. Ltd.) Company Details
    • 13.10.2 Dendreon Corporation (Sanpower Group Co. Ltd.) Business Overview
    • 13.10.3 Dendreon Corporation (Sanpower Group Co. Ltd.) Prostate Cancer Therapeutics Introduction
    • 13.10.4 Dendreon Corporation (Sanpower Group Co. Ltd.) Revenue in Prostate Cancer Therapeutics Business (2015-2020)
    • 13.10.5 Dendreon Corporation (Sanpower Group Co. Ltd.) Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Prostate Cancer Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Prostate Cancer Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Sanofi
    Pfizer
    Amgen
    Johnson & Johnson
    AstraZeneca
    AbbVie
    Bayer
    Ipsen Group
    Endo Pharmaceuticals
    Dendreon Corporation (Sanpower Group Co. Ltd.)

    Market segment by Type, the product can be split into
    Drugs
    Medical Devices
    Market segment by Application, split into
    Hospital Pharmacy
    Retail Pharmacy
    Online Sales

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now